Agarwal R, Green JB, Heerspink HJL, Mann JFE, et al. Impact of Baseline GLP-1 Receptor Agonist Use on Albuminuria Reduction and Safety With Simultaneous Initiation of Finerenone and Empagliflozin in Type 2 Diabetes and Chronic Kidney Disease (CONFIDENCE Trial). Diabetes Care 2025 Sep 19:dc251673. doi: 10.2337/dc25-1673.
PMID: 40968755